002932 明德生物
已收盘 02-13 15:00:00
资讯
新帖
简况
明德生物新注册《EasyPoint POCT智慧管理系统V1.0.0》项目的软件著作权
证券之星 · 02-12
明德生物新注册《EasyPoint POCT智慧管理系统V1.0.0》项目的软件著作权
明德生物两笔收购背后的隐忧：主业承压下的扩张赌局？
新浪证券 · 02-06
明德生物两笔收购背后的隐忧：主业承压下的扩张赌局？
明德生物（002932）披露增资并收购蓝怡（湖南）医疗器械有限公司股权进展公告，2月5日股价上涨0.21%
证券之星 · 02-05
明德生物（002932）披露增资并收购蓝怡（湖南）医疗器械有限公司股权进展公告，2月5日股价上涨0.21%
股市必读：明德生物（002932）预计2025年全年扣非后净利润亏损7800万元至9800万元
证券之星 · 02-02
股市必读：明德生物（002932）预计2025年全年扣非后净利润亏损7800万元至9800万元
双线并购补短板，明德生物密集推进股权收购计划
新京报 · 01-30
双线并购补短板，明德生物密集推进股权收购计划
明德生物（002932）披露重大资产重组进展公告，1月29日股价下跌0.77%
证券之星 · 01-29
明德生物（002932）披露重大资产重组进展公告，1月29日股价下跌0.77%
明德生物(002932)1月20日股东户数2.48万户，较上期减少15.73%
证券之星 · 01-28
明德生物(002932)1月20日股东户数2.48万户，较上期减少15.73%
明德生物：公司收购围绕主业协同与核心竞争力提升展开
证券之星 · 01-28
明德生物：公司收购围绕主业协同与核心竞争力提升展开
明德生物：公司通过成都君蓉康创业投资合伙企业（有限合伙）间接投资北京智冉医疗科技有限公司的比例极小
证券之星 · 01-28
明德生物：公司通过成都君蓉康创业投资合伙企业（有限合伙）间接投资北京智冉医疗科技有限公司的比例极小
明德生物最新公告：拟共同投资设立私募基金投向光互联、半导体等人工智能基础设施/终端产业链
证券之星 · 01-20
明德生物最新公告：拟共同投资设立私募基金投向光互联、半导体等人工智能基础设施/终端产业链
明德生物最新公告：拟3570万元增资并收购湖南蓝怡51%股权
证券之星 · 01-19
明德生物最新公告：拟3570万元增资并收购湖南蓝怡51%股权
明德生物（002932）披露关于变更签字会计师的公告，1月13日股价上涨1.01%
证券之星 · 01-13
明德生物（002932）披露关于变更签字会计师的公告，1月13日股价上涨1.01%
明德生物(002932)12月31日股东户数2.94万户，较上期增加30.91%
证券之星 · 01-06
明德生物(002932)12月31日股东户数2.94万户，较上期增加30.91%
华为、英伟达角逐AI数据平台，存储成AI竞争前沿
21世纪经济报道 · 01-05
华为、英伟达角逐AI数据平台，存储成AI竞争前沿
每周股票复盘：明德生物（002932）拟收购武汉必凯尔100%股权
证券之星 · 01-03
每周股票复盘：明德生物（002932）拟收购武汉必凯尔100%股权
明德生物（002932）披露筹划重大资产重组暨签署《股权收购意向协议》的提示性公告，12月30日股价上涨0.06%
证券之星 · 2025-12-30
明德生物（002932）披露筹划重大资产重组暨签署《股权收购意向协议》的提示性公告，12月30日股价上涨0.06%
明德生物最新公告：拟现金收购武汉必凯尔救助用品有限公司100%股权预计构成重大资产重组
证券之星 · 2025-12-30
明德生物最新公告：拟现金收购武汉必凯尔救助用品有限公司100%股权预计构成重大资产重组
明德生物：截至2025年12月19日股东户数为22449户
证券之星 · 2025-12-23
明德生物：截至2025年12月19日股东户数为22449户
12月15日明德生物现998.75万元大宗交易
证券之星 · 2025-12-15
12月15日明德生物现998.75万元大宗交易
超4.6亿元坏账计提背后的转型痛：昔日“检测王”明德生物深陷843天回款困局
每日经济新闻 · 2025-12-02
超4.6亿元坏账计提背后的转型痛：昔日“检测王”明德生物深陷843天回款困局
加载更多
公司概况
公司名称：
武汉明德生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2018-07-10
主营业务：
武汉明德生物科技股份有限公司的主营业务是体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品是体外诊断试剂和仪器、急危重症信息化解决方案、第三方医学检验服务。2023年2月，公司被授予2022年度“光谷质量奖·卓越奖”，此次荣获“光谷质量奖·卓越奖”是东湖高新区对公司高质量发展的充分认可及鼓励。2024年2月，公司被武汉市人民政府授予“第八届武汉市市长质量奖”。
发行价格：
20.45
{"stockData":{"symbol":"002932","market":"SZ","secType":"STK","nameCN":"明德生物","latestPrice":18.7,"timestamp":1770966183000,"preClose":18.75,"halted":0,"volume":1330369,"delay":0,"changeRate":-0.0027,"floatShares":156000000,"shares":233000000,"eps":0.0306,"marketStatus":"已收盘","change":-0.05,"latestTime":"02-13 15:00:00","open":18.75,"high":18.89,"low":18.69,"amount":25003800,"amplitude":0.0107,"askPrice":18.7,"askSize":10,"bidPrice":18.69,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.0306,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":18.75,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":20.63,"lowLimit":16.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232520957,"isCdr":false,"pbRate":0.78,"roa":"--","peRate":611.111111,"roe":"0.24%","epsLYR":0.33,"committee":-0.027086,"marketValue":4348000000,"turnoverRate":0.0085,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-02-24。","floatMarketCap":2919000000},"requestUrl":"/m/hq/s/002932","defaultTab":"news","newsList":[{"id":"2610509039","title":"明德生物新注册《EasyPoint POCT智慧管理系统V1.0.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610509039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610509039?lang=zh_cn&edition=full","pubTime":"2026-02-12 02:01","pubTimestamp":1770832876,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物新注册了《EasyPoint POCT智慧管理系统V1.0.0》项目的软件著作权。今年以来明德生物新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4681.89万元，同比减15.22%。通过天眼查大数据分析，武汉明德生物科技股份有限公司共对外投资了24家企业，参与招投标项目706次；财产线索方面有商标信息183条，专利信息218条，著作权信息101条；此外企业还拥有行政许可699个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200001298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2609568121","title":"明德生物两笔收购背后的隐忧：主业承压下的扩张赌局？","url":"https://stock-news.laohu8.com/highlight/detail?id=2609568121","media":"新浪证券","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609568121?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:11","pubTimestamp":1770365460,"startTime":"0","endTime":"0","summary":"一个月内，体外诊断上市公司明德生物接连宣布两笔股权收购，引发市场关注与争议。在自身业绩连续下滑、市值“破净”的背景下，公司仍选择收购一家净资产为负、连续亏损的企业，这究竟是战略布局，还是一场危险的资本赌局？ 明德生物近年业绩并不乐观。然而，当收购方自身业绩疲软、标的公司财务状况堪忧时，此类扩张更应慎之又慎。明德生物的两笔收购能否真正提升核心竞争力、带来可持续盈利，仍需时间检验。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-02-06/doc-inhkwnki2085513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2609309787","title":"明德生物（002932）披露增资并收购蓝怡（湖南）医疗器械有限公司股权进展公告，2月5日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609309787","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609309787?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:33","pubTimestamp":1770301993,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，明德生物报收于19.26元，较前一交易日上涨0.21%，最新总市值为44.78亿元。公告显示，公司于2026年1月19日召开第五届董事会第三次会议，审议通过增资并收购蓝怡（湖南）医疗器械有限公司股权的议案。截至本公告日，湖南蓝怡已完成工商变更登记，公司持有其51%股权，湖南蓝怡成为公司控股子公司，纳入合并报表范围。嘉善禾欣咨询管理合伙企业受让蓝怡集团持有的湖南蓝怡20%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1222","BK1583","002932","09997","09996","BK1100","159883","BK0239"],"gpt_icon":0},{"id":"2608095889","title":"股市必读：明德生物（002932）预计2025年全年扣非后净利润亏损7800万元至9800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608095889","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608095889?lang=zh_cn&edition=full","pubTime":"2026-02-02 04:06","pubTimestamp":1769976376,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，明德生物报收于19.26元，下跌0.47%，换手率2.11%，成交量3.3万手，成交额6358.36万元。明德生物发布业绩预告，预计2025年全年归属净利润盈利1200万元至1800万元。2025年度业绩预告武汉明德生物科技股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为1,200万元至1,800万元，比上年同期下降75.85%至83.90%；扣除非经常性损益后的净利润为-9,800万元至-7,800万元，较上年同期亏损收窄，同比增长30.17%至44.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932"],"gpt_icon":0},{"id":"2607412011","title":"双线并购补短板，明德生物密集推进股权收购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2607412011","media":"新京报","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607412011?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:53","pubTimestamp":1769770380,"startTime":"0","endTime":"0","summary":"武汉明德生物科技股份有限公司近期瞄准应急救护与体外诊断仪器赛道，接连发起股权收购。明德生物此次收购意在聚焦急危重症业务板块发展。1月29日晚，明德生物再发重大资产重组进展公告，本次交易拟采用现金方式，具体交易方案仍在商讨论证中，交易各方尚未签署正式协议，本次交易尚存在较大不确定性。在披露上述资产收购意向后不久，明德生物又披露了另一则股权收购计划。","market":"sh","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl8820261301849492889761.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl8820261301849492889761.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1769770404168200.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1769770404168200.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2607394190","title":"明德生物（002932）披露重大资产重组进展公告，1月29日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607394190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607394190?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:18","pubTimestamp":1769699893,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，明德生物报收于19.35元，较前一交易日下跌0.77%，最新总市值为44.99亿元。该股当日开盘19.51元，最高19.61元，最低19.21元，成交额达7365.34万元，换手率为2.43%。近日，明德生物发布《关于重大资产重组进展的公告》。本次交易尚存在较大不确定性，公司将根据进展履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2606579143","title":"明德生物(002932)1月20日股东户数2.48万户，较上期减少15.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606579143","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606579143?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:32","pubTimestamp":1769592759,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2026年1月20日公司股东户数为2.48万户，较12月31日减少4622.0户，减幅为15.73%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至1月20日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年1月20日，明德生物区间跌幅为1.72%，在此期间股东户数减少4622.0户，减幅为15.73%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800030101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2606752791","title":"明德生物：公司收购围绕主业协同与核心竞争力提升展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2606752791","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606752791?lang=zh_cn&edition=full","pubTime":"2026-01-28 09:06","pubTimestamp":1769562378,"startTime":"0","endTime":"0","summary":"证券之星消息，明德生物01月27日在投资者关系平台上答复投资者关心的问题。公司收购围绕主业协同与核心竞争力提升展开，通过夯实主业提升内在价值。标的选择聚焦产业链互补，旨在进一步提升公司综合服务能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800008276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2606529857","title":"明德生物：公司通过成都君蓉康创业投资合伙企业（有限合伙）间接投资北京智冉医疗科技有限公司的比例极小","url":"https://stock-news.laohu8.com/highlight/detail?id=2606529857","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606529857?lang=zh_cn&edition=full","pubTime":"2026-01-28 08:57","pubTimestamp":1769561826,"startTime":"0","endTime":"0","summary":"证券之星消息，明德生物(002932)01月27日在投资者关系平台上答复投资者关心的问题。投资者提问：根据企业公示信息查询，公司对脑机接口公司北京智冉医疗科技有限公司有间接投资是否属实。明德生物回复：尊敬的投资者您好，公司通过成都君蓉康创业投资合伙企业（有限合伙）间接投资北京智冉医疗科技有限公司的比例极小。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800007899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","BK0239","002932"],"gpt_icon":0},{"id":"2604197689","title":"明德生物最新公告：拟共同投资设立私募基金投向光互联、半导体等人工智能基础设施/终端产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2604197689","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604197689?lang=zh_cn&edition=full","pubTime":"2026-01-20 19:39","pubTimestamp":1768909196,"startTime":"0","endTime":"0","summary":"明德生物(002932.SZ)公告称，公司与武汉泽森长盛创业投资基金管理有限公司等共同签署合伙协议，参与投资武汉泽森聚芯贰号创业投资合伙企业（有限合伙）。基金规模为9,500万元，其中公司作为有限合伙人出资3,000万元，持股比例31.5789%。基金投资范围主要包括未上市企业股权，主要投资行业为光互联、半导体等人工智能基础设施/终端产业链。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000034399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159582","002932","161631"],"gpt_icon":0},{"id":"2604687180","title":"明德生物最新公告：拟3570万元增资并收购湖南蓝怡51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2604687180","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604687180?lang=zh_cn&edition=full","pubTime":"2026-01-19 18:50","pubTimestamp":1768819815,"startTime":"0","endTime":"0","summary":"明德生物公告称，公司与蓝怡科技集团股份有限公司签署《关于蓝怡（湖南）医疗器械有限公司之收购协议》，拟以3570.10万元通过增资及股权收购方式取得蓝怡（湖南）医疗器械有限公司51%股权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900028520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2603850201","title":"明德生物（002932）披露关于变更签字会计师的公告，1月13日股价上涨1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603850201","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603850201?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:47","pubTimestamp":1768297627,"startTime":"0","endTime":"0","summary":"截至2026年1月13日收盘，明德生物报收于19.0元，较前一交易日上涨1.01%，最新总市值为44.18亿元。公司于近日发布公告称，武汉明德生物科技股份有限公司于2026年1月12日收到立信会计师事务所出具的函件，因工作安排原因，原指派的签字注册会计师刘小华女士变更为刘璐女士，继续完成公司2025年度财务报表及内部控制审计工作。刘璐自2016年起在立信工作，2017年开始从事上市公司审计，2024年取得注册会计师资格，近三年无不良诚信记录，符合独立性要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300030344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2601189389","title":"明德生物(002932)12月31日股东户数2.94万户，较上期增加30.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601189389","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601189389?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:38","pubTimestamp":1767692281,"startTime":"0","endTime":"0","summary":"证券之星消息，近日明德生物披露，截至2025年12月31日公司股东户数为2.94万户，较12月19日增加6938.0户，增幅为30.91%。在医疗器械行业个股中，明德生物股东户数高于行业平均水平，截至12月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年12月19日至2025年12月31日，明德生物区间涨幅为5.97%，在此期间股东户数增加6938.0户，增幅为30.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600029550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2601002796","title":"华为、英伟达角逐AI数据平台，存储成AI竞争前沿","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002796","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601002796?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:36","pubTimestamp":1767605814,"startTime":"0","endTime":"0","summary":"当下AI产业链上，存储是热度最高的环节之一。随着大模型训练与推理规模不断扩大，存储产品市场正在经历一轮显著的上行周期，价格上涨、供给趋紧成为行业共识。在这一现实约束下，如何通过更高效的数据组织、调度与利用，释放有限算力的潜力，正在成为新的竞争焦点。“现在核心痛点在于，很多数据没法被AI直接消费，这会导致AI很难真正快速落地。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601053608914560.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601053608914560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0077335932.USD","LU2552382132.HKD","IE00B4YYXB79.USD","LU0787776722.HKD","LU2083900584.USD","LU1935042215.USD","LU1496350502.SGD","LU0444973449.USD","LU1232071149.USD","LU1037948897.HKD","LU1935042488.USD","IE00BYXW3230.USD","LU0124676726.USD","IE00BQXX3D17.EUR","LU2430703251.USD","LU2746668974.SGD","LU1861127337.USD","LU2552382058.USD","LU0719512351.SGD","LU2505996681.GBP","IE0009356076.USD","LU0353189680.USD","LU0061474705.USD","LU2491049909.HKD","LU0097036916.USD","LU1935043023.USD","LU0267386448.USD","LU1989772923.USD","LU2756315664.SGD","LU0080751232.USD","LU0210536198.USD","NVDX","LU0320765059.SGD","IE00BDRTCR15.USD","LU1791710400.SGD","IE0009G5SDU7.USD","LU1244550494.USD","LU0082616367.USD","LU1804176565.USD","LU1934455194.USD","IE00BJTD4V19.USD","LU1366192091.USD","IE00B5949003.HKD","LU2756315318.SGD","LU0234570918.USD","IE00BZ1G4Q59.USD","LU2250418816.HKD","LU2463028550.USD","LU0072462426.USD","IE00B775H168.HKD","LU0786609619.USD","LU2592432038.USD","LU0256863902.USD","LU2242650005.HKD","LU2505996509.AUD","LU0215105999.USD","SGXZ31699556.SGD","LU0203201768.USD","LU2125909593.SGD","SG9999002224.SGD","LU1571399168.USD","LU1066051811.HKD","LU0964807845.USD","LU0210533765.USD","LU1699723380.USD","SGXZ81514606.USD","LU2168564065.EUR","LU0979878070.USD","LU2452424414.USD","SG9999014898.SGD","SGXZ99366536.SGD","LU1435385759.SGD","LU2092937148.SGD","SG9999014559.SGD","IE000YTNTUN2.SGD","LU1066051498.USD","NVDS.UK","LU0942090050.USD","HK0000320264.USD","LU0070217475.USD","BK4608","3NVD.UK","IE00B3M56506.USD","LU2125154935.USD","LU1778281490.HKD","LU2089985449.USD","LU2237438978.USD","LU2087625088.SGD","LU0689472784.USD","LU2108987350.USD","LU1868836914.USD","LU1923622614.USD","LU1791710582.SGD","IE0003U64NQ7.SGD","IE0004445239.USD","LU0957791311.USD","LU0109392836.USD","LU0476273544.USD","LU0057025933.USD","LU1951198990.SGD","LU2065171311.SGD","LU0198837287.USD","LU0079474960.USD","SG9999001424.SGD","NVD2.UK","LU2746668461.USD","LU0347712357.USD","LU1642822529.SGD","LU1989764748.USD","LU2491050071.SGD","SG9999014575.USD","BK4548","BK4612","LU1429558221.USD","LU0316494557.USD","LU1119994496.HKD","LU2211815571.USD","BK4549","LU2458330169.SGD","IE00B1XK9C88.USD","LU0640476718.USD","BK4532","LU1267930490.SGD","LU0345768153.USD","LU2491050154.USD","LU2750360641.GBP","LU2063271972.USD","BK4587","IE00BJJMRY28.SGD","NVDU","LU1989764664.SGD","LU2242649171.HKD","LU2430703095.HKD","LU0557290698.USD","LU1839511570.USD","LU1934455863.HKD","LU0094547139.USD","IE00B1BXHZ80.USD","IE00BN29S564.USD","IE00B19Z9505.USD","LU0109391861.USD","LU2249611893.SGD","SG9999018865.SGD","LU0096364046.USD","LU1935043536.SGD","SG9999015945.SGD","NVDD","LU1923623000.USD","LU2092627202.USD","LU2125154778.USD","LU0274383776.USD","LU1551013342.USD","LU2458330243.SGD","LU1983260115.SGD","LU1868836591.USD","LU1267930730.SGD","LU2213496289.HKD","IE00BFSS7M15.SGD","LU0345769128.USD","LU1629891620.HKD","HK0000306685.HKD","LU0225283273.USD","LU0683600562.USD","LU2360032135.SGD","LU1974910355.USD","LU0238689110.USD","HK0000320223.HKD","LU2361045086.USD","LU2023251221.USD","LU2456880835.USD","LU0965509283.SGD","IE00BK4W5L77.USD","LU2168564149.EUR","LU2361044865.SGD","LU1934455277.USD","LU0265550946.USD","LU2433249047.HKD","SG9999000418.SGD","LU0472753341.HKD","SG9999018857.SGD","IE0034235295.USD","LU0868494617.USD","SG9999015341.SGD","LU2023250504.SGD","LU1720051108.HKD","IE00BWXC8680.SGD","LU0211327993.USD","LU1989772840.SGD","LU1066051225.USD","IE00B4JS1V06.HKD","BK4527","IE00BJTD4N35.SGD","LU0210528500.USD","LU2322448957.HKD","BK4585","LU1244550221.USD","LU2125909916.SGD","LU1623119135.USD","BK4588","002932","BK4598","LU0353189763.USD","LU1145028129.USD","IE00BJLML261.HKD","LU2272731600.USD","LU0308772762.SGD","LU0345769631.USD","LU0417517546.SGD","LU2168564495.EUR","IE00B3SWFQ91.USD","LU1814569148.SGD","BK4141","BK4614","LU0069063385.USD","NVDY","LU1852331112.SGD","IE00BQXX3F31.USD","IE000ITXATA3.USD","LU0170899867.USD","LU0354030438.USD","SNVD.UK","LU1718418525.SGD","LU1917777945.USD","LU1066053197.SGD","SG9999002232.USD","LU0276348264.USD","LU2168563687.JPY","IE00BFSS8Q28.SGD","LU1923622291.USD","LU2264538146.SGD","NVDA","LU2290526834.HKD","LU2028103732.USD","LU0943347566.SGD","BK4551","LU0965509101.SGD","BK4550","LU0154236417.USD","LU1633808545.USD","LU2896262040.SGD","IE000W1ABFV2.USD","IE00BHPRN162.USD","LU1069344957.HKD","LU0511384066.AUD","LU2403377893.USD","LU0234572021.USD","LU0820562030.AUD","LU1496350171.SGD","LU0061475181.USD","LU0985320562.USD","SG9999014880.SGD","IE0004445015.USD","BK4554","LU0048584097.USD","LU0323591593.USD","LU1721428933.USD","LU1244550577.SGD","IE0001KFT4U8.USD","LU2860962120.EUR","LU0345770308.USD","LU2272731782.SGD","LU2417539215.USD","LU0029864427.USD","BK4503","LU1821325948.USD","LU0266013472.USD","LU2089283258.USD","IE00BQXX3C00.GBP","LU0345770993.USD","LU1035775433.USD","IE00BDCRKT87.USD","LU0158827781.USD","LU2360106780.USD","IE00BMPRXQ63.HKD","BK4579","LU1868836757.USD","SG9999014914.USD","LU0689626769.HKD","IE00B19Z8W00.USD","BK4543","LU1868837136.USD","BK4605","LU2361044949.HKD","IE0004091025.USD","LU0053666078.USD","LU2097344431.USD","LU0957808578.USD","LU2125909247.SGD","LU2286300806.USD","LU1815333072.USD","LU0466842654.USD","LU2326559502.SGD","IE0005OL40V9.USD","IE00BKPKM429.USD","LU1242518857.USD","NVIW.SI","LU1803068979.SGD","LU0348723411.USD","IE00BKVL7J92.USD","LU0823421416.USD","LU0256863811.USD","SG9999017495.SGD","LU0444971666.USD","LU0642271901.SGD","SG9999015952.SGD","2NVD.UK","LU1935042991.SGD","LU2265009873.SGD","LU2462157665.USD","LU1316542783.SGD","SG9999014542.SGD","LU0354030511.USD","LU0289960550.SGD","LU2111349929.HKD","IE00B19Z8X17.USD","LU1548497426.USD","LU0820561909.HKD","LU0823434740.USD","LU1914381329.SGD","LU2381873111.SGD","NVD3.UK","LU1861220033.SGD","IE00BMPRXR70.SGD","LU0965508806.USD","LU2471134952.CNY","LU0390134368.USD","LU0868494708.USD","IE000KEQY171.SGD","LU2023250330.USD","LU0096362180.USD","SGXZ23171101.USD","LU1988902786.USD","LU1323610961.USD","BK4534","LU2087621335.USD","LU0081259029.USD","LU2322448791.USD","LU0861579265.USD","LU0965509010.AUD","LU2420271590.USD","IE00BMPRXN33.USD","LU0823434583.USD","LU1674673691.USD","LU0882574139.USD","LU2125909759.SGD","LU1366333091.USD","LU0128525929.USD","LU0265550359.USD","LU2065169927.USD","LU2247934214.USD","HK0000306701.USD","LU1084165304.USD","LU1116320901.HKD","BK4567","LU0823421333.USD","LU0056508442.USD","LU0175139822.USD","SG9999015978.USD","LU2236285917.USD","IE0034235303.USD","LU0310800379.SGD","LU1116320737.USD","LU2487616109.SGD","NVDL","BK4581","LU1261432733.SGD","LU1868837300.USD","LU2413666699.HKD","LU2191332357.HKD","LU2552382215.SGD","LU0203202063.USD","LU0494093205.USD","LU1992135399.USD","LU1551013425.SGD","LU0289739343.SGD","LU0289961442.SGD","LU2602419157.SGD","LU2473716301.USD","LU2357125470.USD","LU2271345857.HKD","LU1815336760.USD","LU0158827948.USD","LU0107464264.USD","LU2054465674.USD","LU0211328371.USD","LU0061474960.USD","LU2413666426.HKD","LU0672654240.SGD","IE0034235188.USD","LU2750360997.AUD","LU1280957306.USD","IE00BK4W5M84.HKD","LU2065170008.USD","LU2543165471.USD","LU2506951792.HKD","LU1992135472.HKD","LU2294711713.HKD","LU0187121727.USD","LU1861215975.USD","LU2237957902.USD","LU2065171402.SGD","LU2272731865.HKD","LU0251132253.USD","IE00BKDWB100.SGD","LU2471134796.USD","LU2931357623.SGD","SG9999015358.SGD","LU0127658192.USD","BK4529","BK4533","LU2471134523.USD","LU0345768740.USD","LU0310799852.SGD","LU2430703178.SGD","LU0724617625.USD","IE0004086264.USD","LU1674673428.USD","LU1951200564.SGD","LU0823414551.USD","LU1712237335.SGD","LU0006306889.USD","SG9999015986.USD","LU1720051017.SGD","LU0157215616.USD","NVDS","LU1267930573.SGD","LU0823414478.USD","LU0889565833.HKD","LU1691799644.USD","LU2461242641.AUD","LU2168564222.USD","LU0708995401.HKD","IE00BZ199S13.USD","SG9999004303.SGD","LU1127390331.HKD","LU2097344357.USD","LU1037948541.HKD","LU0708994859.HKD","GB00BDT5M118.USD","LU0342679015.USD","LU2077746001.SGD","LU2357305700.SGD","LU0528227936.USD","LU2089284900.SGD","LU0788109477.HKD","BK4592","LU2106854487.HKD","LU2360107168.USD","LU0106261372.USD","LU2471134879.HKD","IE00BD6J9T35.USD","SGXZ51526630.SGD","LU1064131342.USD","LU2237957811.SGD","IE00BJJMRX11.SGD","LU2244417387.USD","SG9999014567.USD","LU1242518931.SGD","SG9999014906.USD","LU0820561818.USD","IE00B7KXQ091.USD","NVD"],"gpt_icon":0},{"id":"2600678860","title":"每周股票复盘：明德生物（002932）拟收购武汉必凯尔100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2600678860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600678860?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:25","pubTimestamp":1767378312,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，明德生物报收于19.18元，较上周的17.77元上涨7.93%。本周，明德生物12月31日盘中最高价报19.48元。明德生物当前最新总市值44.6亿元，在医疗器械板块市值排名79/127，在两市A股市值排名3668/5181。本周关注点公司公告汇总：明德生物拟以现金收购武汉必凯尔100%股权，构成重大资产重组。本次交易尚处于筹划阶段，需经尽职调查、审计评估、正式协议签署及审批程序，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000502.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2595580713","title":"明德生物（002932）披露筹划重大资产重组暨签署《股权收购意向协议》的提示性公告，12月30日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595580713","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595580713?lang=zh_cn&edition=full","pubTime":"2025-12-30 22:39","pubTimestamp":1767105554,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘，明德生物报收于17.82元，较前一交易日上涨0.06%，最新总市值为41.44亿元。公司近日发布公告称，武汉明德生物科技股份有限公司于2025年12月29日与蓝帆医疗股份有限公司签署《股权收购意向协议》，拟以现金方式收购其持有的武汉必凯尔救助用品有限公司100%股权。本次交易构成重大资产重组，不涉及发行股份，不构成关联交易，不会导致公司控股股东及实际控制人变更。公司提醒投资者注意风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000044545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2595962717","title":"明德生物最新公告：拟现金收购武汉必凯尔救助用品有限公司100%股权预计构成重大资产重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2595962717","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595962717?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:30","pubTimestamp":1767090601,"startTime":"0","endTime":"0","summary":"明德生物(002932.SZ)公告称，公司与蓝帆医疗签署《股权收购意向协议》，拟以现金方式收购武汉必凯尔救助用品有限公司100%股权。预计本次交易构成重大资产重组，不构成重组上市，不涉及发行股份。交易完成后，标的公司将成为公司的全资子公司。标的公司是较早引入国际第一急救（FirstAid）理念和技术的企业，主要从事以急救包为核心，全面布局应急装备、应急单品和应急服务的应急救护业务。此次整合将有力推动公司急危重症诊疗一体化业务从医疗机构向工业场景与家庭场景延伸。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123000032351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2593939463","title":"明德生物：截至2025年12月19日股东户数为22449户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593939463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593939463?lang=zh_cn&edition=full","pubTime":"2025-12-23 11:36","pubTimestamp":1766461005,"startTime":"0","endTime":"0","summary":"证券之星消息，明德生物(002932)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，请问截止到2025年12月19日，贵公司股东户数是多少？谢谢啦！！！明德生物回复：尊敬的投资者您好，截至2025年12月19日，公司股东总户数为22449户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300014778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"gpt_icon":0},{"id":"2591612636","title":"12月15日明德生物现998.75万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612636?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:41","pubTimestamp":1765791670,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日明德生物发生大宗交易，交易数据如下：大宗交易成交价格15.98元，相对当日收盘价折价9.36%，成交62.5万股，成交金额998.75万元，买方营业部为国泰海通证券股份有限公司成都双庆路证券营业部，卖方营业部为平安证券股份有限公司湖北分公司。近三个月该股共发生2笔大宗交易，合计成交1.25万手，折价成交2笔。截至2025年12月15日收盘，明德生物报收于17.63元，下跌0.68%，换手率1.65%，成交量2.57万手，成交额4524.88万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"gpt_icon":0},{"id":"2588005922","title":"超4.6亿元坏账计提背后的转型痛：昔日“检测王”明德生物深陷843天回款困局","url":"https://stock-news.laohu8.com/highlight/detail?id=2588005922","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588005922?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:12","pubTimestamp":1764684720,"startTime":"0","endTime":"0","summary":"根据2025年11月的一份行业统计，截至今年前三季度，在132家医疗器械企业中，明德生物的应收账款周转天数长达843天，远超100家上榜企业平均136天的天数。明德生物应收账款周转超过800天 上述统计数据显示，回款效率较低的企业集中在体外诊断领域。明德生物解释，这是收入大幅增加和客户回款速度放缓所致。到了今年7月，明德生物的说法变成了“公司高度重视应收账款回收工作，采取多种手段积极催收”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-02/doc-infzmppc0216896.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-02/doc-infzmppc0216896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002932"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771381405414,"stockEarnings":[{"period":"1week","weight":-0.0194},{"period":"1month","weight":-0.0189},{"period":"3month","weight":-0.0743},{"period":"6month","weight":-0.0997},{"period":"1year","weight":0.0425},{"period":"ytd","weight":-0.025}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉明德生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24765人(较上一季度减少15.73%)","perCapita":"6302股","listingDate":"2018-07-10","address":"湖北省武汉市江夏区东湖新技术开发区九龙中路77号武汉明德生物科技产业园(一期)(全部自用)1栋1单元1层1号C区","registeredCapital":"23252万元","survey":" 武汉明德生物科技股份有限公司的主营业务是体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品是体外诊断试剂和仪器、急危重症信息化解决方案、第三方医学检验服务。2023年2月，公司被授予2022年度“光谷质量奖·卓越奖”，此次荣获“光谷质量奖·卓越奖”是东湖高新区对公司高质量发展的充分认可及鼓励。2024年2月，公司被武汉市人民政府授予“第八届武汉市市长质量奖”。","listedPrice":20.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"明德生物,002932,明德生物股票,明德生物股票老虎,明德生物股票老虎国际,明德生物行情,明德生物股票行情,明德生物股价,明德生物股市,明德生物股票价格,明德生物股票交易,明德生物股票购买,明德生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"明德生物(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供明德生物(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}